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Background. South Africa (SA) has one of the largest HIV/AIDS epidemics in the world and the most extensive antiretroviral therapy 
(ART) programme globally, which was rolled out from 2004. This paper reports the trends in HIV/AIDS mortality pre and post ART rollout 
in SA.
Methods. Vital registration cause-of-death data from Statistics South Africa were adjusted for under-reporting of deaths using demographic 
methods. Misattributed HIV/AIDS deaths were identified by regressing excess mortality on a lagged indicator HIV antenatal clinic 
prevalence for causes found to be associated with HIV/AIDS. Background trends in the source-cause mortality rates were estimated from 
the trend in cause-specific mortality experienced among 75 - 84-year-olds. Mortality rates were calculated using mid-year population 
estimates and the World Health Organization world standard age-weights.
Results. We estimated over 3 189 000 HIV/AIDS deaths for 1997 - 2012. In 1997, 60 336 (14.5%) of deaths were attributed to HIV/AIDS; 
this number peaked in 2006 at 283 564 (41.9%) and decreased to 153 661 (29.1%) by 2012; female mortality rates peaked in 2005 and those 
of males in 2006. Men aged 35 years and older had higher mortality rates than did women. While the rates at ages below 65 years in 2012 
were lower than those in 2006, rates of those age 65 years and older remained unchanged.
Conclusion. The number of HIV/AIDS deaths has almost halved since the ART rollout. Of concern is the high mortality in men 45 years 
and older and the high mortality of men compared with women in the older ages by 2012; this gap has increased with age. Treatment and 
prevention programmes should strategise how to target men.
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South Africa (SA) is one of the countries worst affected by the 
HIV/AIDS epidemic and has the most extensive publicly provided 
antiretroviral therapy (ART) programmes in sub-Saharan Africa.[1] 
This programme began in 2004.[2] The Human Sciences Research 
Council has been conducting national HIV prevalence, incidence, 
behaviour and communication surveys at three-yearly intervals since 
2002; consequently, national and provincial trends in prevalence, 
incidence and behaviour are available for the country.[3-6] However, 
there are few empirical estimates of HIV/AIDS mortality at national 
and provincial levels for SA. Tracking trends in HIV/AIDS mortality 
is paramount to understanding the progress made before and after the 
ART programme rollout in the country. To date, this has been done 
through model estimates which in recent years (e.g. Thembisa)[7,8] 
have calibrated the model to the total number of deaths experienced 
but not to cause-specific mortality. 
SA has a vital registration system that routinely collects cause-of-
death information that is processed and released by Statistics South 
Africa (Stats SA). Stats SA clearly states in their mortality and causes 
report that ‘The quality of the causes of mortality statistics depends on 
the completeness and accuracy of the certified death notification forms. 
When coding causes-of-death statistics, the coders at Stats SA follow 
the principle of ‘what you see is what you code.’[9] As a consequence, 
Stats SA does not adjust for misattributed HIV/AIDS deaths; this is a 
huge problem in SA, as medical doctors still report HIIV/AIDS deaths 
as due to other causes, because stigma and discrimination still exist 
around the disease.[10] This trend is reflected by the low proportion 
of deaths reported to HIV/AIDS by Stats SA; for example, 3.8% in 
2012.[11] As part of the second National Burden of Disease Study, led by 
the South African Medical Research Council (SA MRC), Bradshaw and 
colleagues[12] developed a method for identifying misattributed HIV/
AIDS deaths which were then reallocated to HIV/AIDS. The present 
paper reports a comprehensive analysis of HIV mortality focusing on 
trends by sex, age and province that formed part of the second National 
Burden of Disease study (NBDS 2)[13] and assesses the impact of ART 
by focusing on the pre- and post-ART rollout periods. Although model 
estimates of the number of HIV-related deaths have indicated the 
impact of ART,[7,14] this work provides estimates based on empirical 
data on the impact of ART.
Methods
The methodology used in the NBDS 2 has been well documented 
elsewhere.[12,13,15] Briefly, the vital registration cause-of-death data 
from Stats SA for the years 1997 - 2012 were adjusted for under-
reporting of deaths using demographic methods.[11,15] Kaposi’s sarcoma 
(C46), HIV pseudonyms such as ‘retroviral disease’ and ‘immune 
suppression’ (B33, B45, B59 and D84) were added to the HIV/AIDS 
(B20 - B24) deaths. Misattributed HIV/AIDS deaths were identified 
by regressing excess mortality on a lagged indicator HIV antenatal 
clinic prevalence.[12] Background trends in the source-cause mortality 
rates were estimated by extrapolating rates in 1995 (i.e. before the 
impact of HIV), using the trend in cause-specific mortality experienced 
among 75 - 84-year-olds (assumed to be largely free of AIDS deaths).[12] 
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Mortality rates were calculated using mid-
year population estimates[16] and the World 
Health Orgnization (WHO) world standard 
age-weights.[17] The causes of death that were 
estimated to include the misattributed AIDS 
deaths are presented by age and sex. Changes 
in the number of AIDS deaths and the age-
specific death rate are presented for selected 
years (1997, 2000, 2006 and 2012) to track 
the progression of AIDS mortality during 
the different periods of ART availability, and 
the provincial trends in AIDS mortality are 
presented to highlight the differential impact 
across the country.
Results
Identifying AIDS deaths
Using the methods of Bradshaw et al,[12] over 
3 189 000 HIV/AIDS deaths were estimated for 
the period 1997 - 2012. Most of the HIV/AIDS 
deaths were misattributed to other conditions; 
23% were misattributed to tuberculosis 
(TB) (i.e. 69% of reported TB deaths), 15% 
to lower respiratory infections (i.e. 60% of 
reported lower respiratory infections deaths), 
10% to diarrhoeal disease (i.e. 57% of 
reported diarrhoeal disease deaths) and 18% 
to ill-defined deaths (i.e.  38% of reported 
ill-defined deaths). Only 7% of all HIV/AIDS 
deaths were reported as HIV/AIDS. There 
was no significant difference in the pattern 
of misattributed deaths by sex within each 
age group except for females 15 - 19 years 
old who had more than 3 times more AIDS 
deaths than males across all the categories of 
misattributed deaths (Figs 1a and 1b).
AIDS deaths
In 1997, 60 336 (14.5%) of deaths were 
attributed to HIV/AIDS; this number peaked 
in 2006 at 283 564 (41.9%) and decreased to 
153 661 (29.1%) by 2012;[13] female mortality 
rates peaked in 2005 and those of males in 
2006 (data not shown).
By 2012, there was a dramatic decrease in 
the number of HIV/AIDS deaths in children 
<1 year of age – amounting to only one-third 
of the deaths compared with 1997 (Fig.  2). 
A less pronounced decrease occurred for 
children 1 - 4 years old. The numbers in 
other age groups did not decline to the 
same extent, with none yet falling to 1997 
levels by 2012. The numbers of deaths in 
all age groups, except those ≥60 years, were 
noticeably lower in 2012 than in 2006.
Disaggregating the analysis by sex and 
calculating mortality rates, which account for 
population size in each age and sex group, 
revealed interesting male-female differences 
(Figs 3a and 3b). In the 25 - 34-year age 
group, women had higher mortality rates 
than did men. This pattern reversed in the 
≥45 years age groups. While the rates in 
2012 are lower than those in 2006 at all ages 
<65 years, and lower than those in 2000 at 
ages <35 years, there was little improvement 
since 2006 in the rates of those ≥65 years old.
None of the 9 provinces in SA had by 2012 
reached levels of HIV/AIDS mortality rates 
similar or lower than those of 1997 (Fig.  4). 
KwaZulu-Natal experienced the highest HIV/
AIDS mortality rates throughout the period, 
followed (closely in the more recent years) 
by the Free State and then Mpumalanga. The 
Age group (years)
Age group (years)
 Reported HIV  HIV pseudonyms  Tuberculosis
 Diarrhoeal disease  Lower respiratory infections  Other causes
300 000
250 000
200 000
150 000
100 000
50 000
0
b. Females
350 000
300 000
250 000
200 000
150 000
100 000
50 000
0
<1
1 
- 4
 
 5
 - 
14
 
 1
5 
- 1
9 
20
 - 
24
 
25
 - 
29
 
30
 - 
34
 
 3
5 
- 3
9 
 4
0 
- 4
4 
 4
5 
- 4
9 
50
 - 
54
 
55
 - 
59
 
 6
0 
- 6
4 
 ≥
65
 
1 
- 4
 
 5
 - 
14
 
 1
5 
- 1
9 
20
 - 
24
 
25
 - 
29
 
30
 - 
34
 
 3
5 
- 3
9 
 4
0 
- 4
4 
 4
5 
- 4
9 
50
 - 
54
 
55
 - 
59
 
 6
0 
- 6
4 
 ≥
65
 
H
IV
/A
ID
S 
de
at
hs
, N
H
IV
/A
ID
S 
de
at
hs
, N
a. Males350 000
Ill-dened
 Reported HIV  HIV pseudonyms  Tuberculosis
 Diarrhoeal disease  Lower respiratory infections  Other causes
Ill-dened
<1
Figs 1a and 1b. Estimated number of HIV/AIDS deaths by reported cause of death by sex and age for 
the period 1997 - 2012.
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Fig. 2. Number of HIV/AIDS deaths by age group for 1997, 2000, 2006 and 2012.
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Western Cape (WC), which consistently had the lowest HIV/AIDS 
mortality compared with other provinces, showed an increase until 
2003 and little change in HIV/AIDS mortality thereafter; this differs 
from the characteristic HIV/AIDS trend in the rates of the other 
provinces, with the exception of Northern Cape (NC).
Discussion
Our study estimates that over three million HIV/AIDS 
deaths occurred between 1997 and 2012 and shows that, 
even though there have been gains in the battle against the 
HIV/AIDS epidemic in SA, by 2012 the country had yet to reach 
mortality levels experienced in 1997 (the earliest measure of the 
national number of HIV/AIDS deaths in the country from registered 
deaths). That said, Dorrington et al.[18] estimated some HIV/AIDS 
deaths in 1992/1993 from their projections using the ASSA600 AIDS 
and Demographic model. HIV/AIDS was still the leading cause of 
death in SA by 2012, even though the number of HIV/AIDS deaths had 
almost halved since the rollout of ART.[13]
SA’s biggest success against the HIV/AIDS epidemic was among 
children under age 5, where the number of deaths under age 1 was a 
third of those reported in 1997, and those aged 1 - 4 years were less 
in 2012 than in 1997. This reduction was due to the provision of ART 
to women, which reduced the transmission of HIV from mother to 
child.[19]
The finding that rates for men ≥45 years did not decline much with 
age in 2012, and the rate for men ≥65 years having not decreased 
since 2006, is a concern. The gap between rates of men and women 
increased in 2012, with the rate for men being 1.5 times higher than 
that for women in the 45 - 54-year age group, 2 times higher in the 55 
- 64-year age group, and 2.5 times higher in the >65 years age group. 
This male-female mortality differential and the challenge of high 
mortality among older men has been shown by Cornell et al. [20] in a 
local study and was attributed to men entering the ART programme 
at an older age with an advanced stage of disease. Cornell et al.[20] also 
reported that more women than men entered the ART programme 
in their small area study. The Joint United Nations Programme on 
HIV/AIDS (UNAIDS) has recognised that HIV response activities 
need to also focus on men, and launched the UNAIDS Platform for 
Action on men and HIV[21] at the International AIDS Conference 
held in SA in July 2016. They identified that gender inequalities and 
harmful gender norms are important drivers of the HIV epidemic, 
which also negatively affects HIV response activities. Furthermore, 
UNAIDS reports that ‘while access to HIV services for women and 
girls remains a concern, a growing body of evidence also shows that 
men and adolescent boys have limited access to HIV services and that 
men are significantly underrepresented in HIV testing and treatment 
and similarly overrepresented in AIDS morbidity and mortality’.[22]
Our provincial findings reveal that HIV/AIDS mortality decreased 
in all provinces since 2005/2006, soon after the intensified rollout 
of the ART programme in 2004. However, by 2012 none of the 
provinces had reached 1997 levels of mortality. The WC had low 
levels of HIV/AIDS mortality, which is in keeping with this province 
having the lowest prevalence of HIV.[23] The levelling of WC mortality 
rates from 2003 may reflect the province’s early response to the 
epidemic through the provision of treatment in demonstration 
projects at government clinics in 2001 and the early scale-up 
through primary care facilities in 2004.[24] The continued increase in 
HIV/AIDS mortality up to 2008 in NC could be indicative of a slower 
response to the ART rollout driven by the widespread and sparse 
distribution of the population in this province.
Over 90% of identified HIV/AIDS deaths were misattributed to 
other conditions, with most of these coming from TB. This tendency 
is partly due to the reluctance of doctors to certify HIV/AIDS as a 
cause of death owing to stigma but also the fact that not all decedents 
had been tested for HIV, particularly in the early period.[10] Efforts 
have been made to address this challenge; for example, the SAMRC, 
Stats SA and the National Department of Health conducted training 
for doctors on medical certification of cause of death in 2012, where 
it was clarified that if HIV is present, it should be indicated on the 
medical certificate completed by the doctor. This issue remains a 
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Figs 3a and 3b. HIV/AIDS mortality rates by sex and age group for 1997, 2000, 2006 and 2012.
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challenge, and further training of doctors in medical certification is 
required.
More needs to be done to integrate health services to ensure 
treatment and care for HIV-positive patients with comorbidities. 
Routine testing for HIV as part of the health services is also needed 
for early diagnosis of HIV-positive individuals presenting with other 
conditions.
The National Burden of Disease Study assumes that there is a single 
underlying cause of death for each decedent. The consequence is to 
underplay the contribution of opportunistic infections, particularly 
TB, because individuals with comorbid HIV have been attributed to 
HIV/AIDS.
In conclusion, even though SA is recognised as a success 
story in the fight against the HIV/AIDS epidemic, the country 
has not yet reached levels of HIV/AIDS mortality similar 
to 1997 – this is 12 years after an intense and extensive ART 
programme rollout. SA may have won many of the battles against 
HIV/AIDS, but the war is not over in all 9 provinces. In the past, 
HIV response activities targeted women and children in SA; however, 
our study – that revealed a surprising lack of improvement in 
mortality among older men – and others have shown that efforts 
also need to focus on getting men to initiate ART earlier with 
less advanced AIDS-related complications. Many have noted that 
men display poor health-seeking behaviour; however, the impact 
this has had on the HIV testing and treatment cascade needs 
attention.[25] Mills et al.[26] noted that ‘Efforts to understand men’s 
health-seeking behavior are poorly understood in the AIDS epidemic 
and encouraging men to get tested and into treatment is a major 
challenge, but one that is poorly recognized’. Tackling the challenge 
of formulating an appropriate HIV response for men is the next step 
for SA, and these activities must include adolescent boys and young 
men to encourage behaviours that promote better future health-
seeking behaviours among men. Furthermore, more focus on the 
integration of health services to treat and care for HIV patients with 
comorbidities and implementing routine testing of patients for HIV 
as part of standard care will contribute to turning the tide against 
HIV/AIDS.
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